← 產業報告目錄
RNAi Therapeutics and Technology Market Size, Share & Trends Analysis Distribution By Type (Small Interfering RNA (siRNA), MicroRNA (miRNA)), By Route of Administration (Intravenous (IV), Subcutaneous), By Delivery (Lipid Nanoparticles (LNPs), Conjugates, Others), By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-23頁數 179報告編號 INSIGHTACE-e8cff1de8a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 1.6 Bn as of 2023, the global RNAi Therapeutics and Technology Market is anticipated to climb to USD 5.28 Bn by 2031, reflecting a compound annual growth rate of 16.0% over the 2024–2031 period.
RNAi Therapeutics and Technology covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNAi Therapeutics and Technology Market Snapshot
Chapter 4. Global RNAi Therapeutics and Technology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Qualitative Information of Technology Platform
4.8.1. Conjugated Delivery Technologies
4.8.1.1. Targeted RNAi Molecule (TRiM) Platform
4.8.1.2. GalXC Conjugated RNAi Technology Platform
4.8.1.3. The Vigil Platform
4.8.1.4. mRNAi GOLD Platform
4.8.2. Centyrin technology
4.8.2.1. Fatty Acid Ligand Conjugated OligoNucleotide (FALCON) platform
4.8.2.2. TERA platform
4.8.2.3. CASi platform
4.8.2.4. GalNAc-RNAi platform
4.9. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Small interfering RNA (siRNA)
5.2.2. MicroRNA (miRNA)
Chapter 6. Market Segmentation 2: by Route of Administration Estimates & Trend Analysis
6.1. by Route of Administration & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
6.2.1. Intravenous (IV)
6.2.2. Subcutaneous
Chapter 7. Market Segmentation 3: by Delivery Estimates & Trend Analysis
7.1. by Delivery & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Delivery:
7.2.1. Lipid Nanoparticles (LNPs)
7.2.2. Conjugates
7.2.3. Others
Chapter 8. RNAi Therapeutics and Technology Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
8.1.2. North America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Delivery, 2023-2031
8.1.3. North America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
8.1.4. North America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
8.2.2. Europe RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Delivery, 2023-2031
8.2.3. Europe RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
8.2.4. Europe RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
8.3.2. Asia Pacific RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Delivery, 2023-2031
8.3.3. Asia-Pacific RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
8.3.4. Asia Pacific RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
8.4.2. Latin America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Delivery, 2023-2031
8.4.3. Latin America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
8.4.4. Latin America RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
8.5.2. Middle East & Africa RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Delivery, 2023-2031
8.5.3. Middle East & Africa RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
8.5.4. Middle East & Africa RNAi Therapeutics and Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Alnylam
9.2.2. Novartis
9.2.3. Novo Nordisk
9.2.4. Regulus therapeutics
9.2.5. miRagen therapeutics
9.2.6. Roche
9.2.7. Santaris
9.2.8. Sanofi Genzyme
9.2.9. AstraZeneca
9.2.10. Viridian
9.2.11. Mirna Therapeutics
9.2.12. Arbutus Biopharma
9.2.13. OliX Pharmaceuticals, Inc
9.2.14. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們